NEWPORT BEACH, CA — (Marketwired) — 07/17/13 — – Viratech Corp. (PINKSHEETS: VIRA)BUYINS.NET, , a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Viratech Corp (PINKSHEETS: VIRA) after releasing the latest short sale data through July 12, 2013. The total aggregate number of shares shorted since May 2013 is approximately 600,187 shares. Approximately 5.94% of daily trading volume is short sell
STOCKTON, CA — (Marketwired) — 05/30/13 — Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today the signing of an agreement for a license issued from Chris Ryan and Kevin Buckman for a patent-pending, provisional application titled "Method of Lowering a Cancer Patient-s Morbidity Rate by Increasing Quality of Life of Patient by Leveraging Cause-Based Electronic Social Support Networks."This invention was created to lower
STOCKTON, CA — (Marketwire) — 02/27/13 — Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today that it has published its e-Book on open source biotech research. The book, "Open Source Cancer Research," by Dr. Kevin Buckman, describes how the first open source biotech research social network platform works to make it possible for individuals or smaller companies to compete with larger companies in the race to patent new me
STOCKTON, CA — (Marketwire) — 02/21/13 — Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today that it has entered into a letter of intent to provide a turn-key Social Network for Diabetes Network Charities at http//diabetes.net, for $250,000, plus 25% royalty from all revenue derived from the operation of the site."Viratech-s method of broadcasting and building content through user generated content is innovative and clever,
STOCKTON, CA — (Marketwire) — 02/19/13 — Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today the launch of Cancer.im, , a social network resource site for cancer patients, survivors, advocates, and volunteers. Cancer.im harnesses social collaboration utilities to develop what Viratech believes will become the first experience-based search engine powered by social collaboration .Cancer.im, a wholly owned subsidiary of Viratech Cor
STOCKTON, CA — (Marketwire) — 01/24/13 — Viratech Corp. (PINKSHEETS: VIRA) announced today that Cancer.im, , designed to be the world-s first experience based social network resource site for people affected by cancer, has released the first of 235 books to be released on Amazon-s Kindle platform, focusing on Cancer.The first book, "Find and Stop Breast Cancer," by Dr. Kevin Buckman, is being offered through Amazon.com through its KDP Select program and can be bought here: , and th
STOCKTON, CA — (Marketwire) — 01/18/13 — Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today that it has entered into a letter of intent to provide a turnkey Social Network for Wellness Builder, Inc., a company engaged in the development of a series of nutraceutical products designed to combat the effects of stress, inadequate nutrition and exposure to environmental toxins."As an inventor of Wellness Builder-s initial key pr
STOCKTON, CA — (Marketwire) — 01/08/13 — Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today the addition of Mort Rothbard MD to its Advisory Board.Morton Rothbard MD, PhD was the Founder of In-Shape City Health Clubs (Inshapeclubs.com), with over 65 Athletic Clubs in the USA. He was awarded the recognition as "Business Man of the Year" in the city of Stockton, California.Dr. Rothbard received his Bachelor of Science fr
STOCKTON, CA — (Marketwire) — 12/20/12 — Viratech Corp. (PINKSHEETS: VIRA) , the first open source biotech research social network platform, announced today an acquisition merger with Cancer.im, Inc., in exchange for $6.2 million in Viratech restricted common stock.Cancer.im, Inc. owns and operates , a social network resource site for cancer patients, survivors, advocates, and volunteers. Cancer.im harnesses social collaboration utilities to develop what Viratech believes will become the fir
